Dr. Reddy’s Laboratories debuts generic version of KOMBIGLYZE XR in US

TAGS

In a significant development for treatment in the U.S., Dr. Reddy’s Laboratories has unveiled its Saxagliptin and Metformin Hydrochloride Extended-Release Tablets. This launch introduces a therapeutic equivalent to the widely prescribed (saxagliptin and metformin hydrochloride extended release) tablets, with the endorsement of the US Food and Drug Administration (FDA).

See also  Shields Health Solutions opens new office in Phoenix, Arizona

The Indian pharmaceutical giant is supplying these tablets in varying strengths to cater to diverse patient needs. Specifically, the 2.5 mg/1000 mg strength comes in a 60-count bottle, while the 5 mg/500 mg and 5 mg/1000 mg strengths are available in 30-count bottles. The introduction of this generic version by signals a significant step in offering cost-effective options for American patients.


Discover more from Business-News-Today.com

Subscribe to get the latest posts sent to your email.

CATEGORIES
TAGS
Share This